Related Experiment Videos
Development of the Clozaril Patient Management System
B Bastani1, L D Alphs, H Y Meltzer
1Department of Psychiatry, Case Western Reserve University School of Medicine, Cleveland, OH 44106.
Psychopharmacology
|January 1, 1989
Summary
The Clozaril Patient Management System (CPMS) ensures safe clozapine treatment by monitoring white blood cell counts (WBCs) and preventing agranulocytosis. This system effectively supports physicians in managing patient blood monitoring and medication distribution.
Area of Science:
- Pharmacovigilance
- Clinical Pharmacy
- Hematology
Background:
- Clozapine treatment requires rigorous monitoring of white blood cell counts (WBCs) due to the risk of agranulocytosis.
- Existing monitoring systems may lack comprehensive data collection and fail-safe mechanisms.
Purpose of the Study:
- To introduce and evaluate the Clozaril Patient Management System (CPMS) in the United States.
- To assess CPMS's effectiveness in monitoring WBCs and collecting data on agranulocytosis in clozapine-treated patients.
Main Methods:
- CPMS utilizes a case administrator and registered pharmacist to facilitate WBC testing at a national laboratory and manage clozapine distribution.
- Key tasks include tracking appointments, ensuring timely lab analysis, and maintaining a patient database.
- Data collection focused on patient characteristics, program satisfaction, and objective achievement.
Main Results:
- Initial experience with 31 patients in an outpatient setting demonstrated CPMS's reliability.
- The system successfully supported physicians in blood monitoring and medication management.
- CPMS met predetermined objectives for patient management and data collection.
Conclusions:
- The Clozaril Patient Management System (CPMS) is an effective and reliable tool for monitoring patients on clozapine.
- CPMS enhances patient safety by providing a fail-safe mechanism against agranulocytosis.
- Comprehensive data collection within CPMS aids in understanding clozapine's adverse effects.